Background Introduction

Inflammation is the body’s defense response to stimulation. In general, the inflammatory reaction of the body often indicates the infection of biological pathogens. For most infectious diseases, the prognosis would be sound with accurate diagnosis and favorable treatment in a timely manner. Therefore, inflammatory markers such as IL-6 have become the detection indicators for clinical diagnosis of infectious diseases.

IL-6 is one of the important cytokines in inflammatory immune response and plays an important role in the early diagnosis of infectious diseases. In the inflammatory reaction, the increase of IL-6 is earlier than other cytokines including PCT and CRP, which can diagnose infection earlier. Studies shows that IL-6 increases rapidly within 1h after bacterial infection, PCT increases after 2h, and CRP increases rapidly after 6h. In addition, the elevated level of IL-6 is consistent with the severity of infection, which can reflect the severity of the disease. Its half-life is shorter than CRP and PCT, which can reflect the effect of antibiotic treatment in a faster pace. Thus, the combined detection of IL-6+PCT+CRP is a common clinical inflammatory detection method.

Recommended Diagnostic Raw Materials

 [Product Information] 

[Product Advantages]

★Wide Linear Range, High Sensitivity!

★High Clinical Agreement Rate

[Product Performance]

Fluorescence Tomography Platform

(1)In the concentration range of 3pg/mL-5000pg/mL, the linear correlation was verified as R2＞99% on the fluorescence chromatography platform.

(2)On the fluorescence chromatography platform, IL-6 paired monoclonal antibody was used to detect the serum assigned by W company renowned internationally, and the sample agreement rate was R2 >98%.

 IL-6 Linear Range 

Agreement Rate of Clinical Serum Assigned by R Company on the Fluorescence       Tomography Platform

Chemiluminescence Platform

(1)In the concentration range of 2pg/mL-4595pg/mL, the linear correlation was verified as R2＞99% on the chemiluminescence platform.

(2)On the chemiluminescence platform, IL-6 paired monoclonal antibody was used to detect the serum assigned by W company renowned internationally, and the sample agreement rate was R2 >97%.

IL-6 Linear Range

 Agreement Rate of Clinical Serum Assigned by W Company on the Chemiluminescence Platform

[Company Background]

Qingdao Henderson Biotechnology Co., Ltd, established in 2016, serves as a professional supplier of core raw materials for in vitro diagnostic reagents and is committed to providing high-quality raw materials for global in vitro diagnostic reagent production enterprises, scientific research institutions and other fields.

The company provides the following staple products: antigens, antibodies, enzymes, etc., widely used in the detection of drug, respiratory infectious diseases (A, B, COVID-19 antigen, COVID-19 antibody, COVID-19 neutralizing antibody, syncytial virus, etc.), other infectious diseases (hepatitis, AIDS, tuberculosis, etc.), markers for tumor, inflammation, myocardial markers, animal diseases detection (dog, cat diseases) and other fields. 

The company, after years of development, has established several specialized laboratories and SPF experimental animal bases, a comprehensive and systematic R&D verification platform and formed a professional technical service team to provide personalized customized services and one-stop solutions.

Qingdao Henderson Biotechnology Co., Ltd is willing to build a renowned product brand for all customers with high-quality products and professional services to keep a foothold in the market with its sound competitiveness.

Limited space only allows the introduction of major products. You are welcomed to contact Qingdao Henderson Biotechnology Co., Ltd and acquire trial samples if you need more information.

Qingdao Henderson Biotechnology Co., Ltd.

Official Website: http://www.qdhenderson.com/

Tel: 0532-84670782

E-mail: info@qdhenderson.com